Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Cardiac Markers Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Cardiac Markers Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Markers Rapid Tests & Point of Care (POC) are rapid diagnostic tests which are simple to perform, ready to use, accurate, economic and for infield use suggested for individuals suspected with any indication.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Markers Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Markers Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Cardiac Markers Rapid Tests & POC Overview
4 Products under Development
4.1 Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
4.2 Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
4.3 Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
4.4 Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date
5 Cardiac Markers Rapid Tests & POC - Pipeline Products under Development by Companies
5.1 Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
5.2 Cardiac Markers Rapid Tests & POC – Companies Pipeline Products by Stage of Development
6 Cardiac Markers Rapid Tests & POC Companies and Product Overview
6.1 Drop Diagnostics Company Overview
6.1.1 Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
6.2 Bio-AMD Inc Company Overview
6.2.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 BiOracle Ltd (Inactive) Company Overview
6.3.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.4 Coris BioConcept Company Overview
6.4.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
6.5 Cue Health Inc Company Overview
6.5.1 Cue Health Inc Pipeline Products & Ongoing Clinical Trials Overview
6.6 Diazyme Laboratories Inc Company Overview
6.6.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 Duke University Company Overview
6.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
6.8 Dynasil Corporation of America Company Overview
6.8.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
6.9 Eachy Biopharmaceuticals Ltd Company Overview
6.9.1 Eachy Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.1 Maxim Biomedical Inc Company Overview
6.10.1 Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 MiCo BioMed Co Ltd Company Overview
6.11.1 MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.12 MyMD Pharmaceuticals Inc Company Overview
6.12.1 MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 Nanomix Inc Company Overview
6.13.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview
6.14 Nanospot.ai Inc Company Overview
6.14.1 Nanospot.ai Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 Novartis AG Company Overview
6.15.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
6.16 Ohmx Corp Company Overview
6.16.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
6.17 Thermo Fisher Scientific Inc Company Overview
6.17.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
6.18 ThreeFold Sensors (Inactive) Company Overview
6.18.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.19 True Diagnostics Inc Company Overview
6.19.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Upstream Medical Technologies Ltd Company Overview
6.20.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Cardiac Markers Rapid Tests & POC- Recent Developments
7.1 Jul 06, 2023: Trinity Biotech Announces Q1 2023 Financial Results
7.2 Jun 27, 2023: bioMErieux’s Executive Committee evolves: Jennifer Zinn appointed Executive Vice President of Clinical Operations
7.3 Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
Table 2: Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
Table 3: Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
Table 4: Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Table 5: Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 6: Cardiac Markers Rapid Tests & POC – Companies Pipeline Products by Stage of Development
Table 7: Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: One Drop Diagnostic Device - Cardiovascular Disease - Product Status
Table 9: One Drop Diagnostic Device - Cardiovascular Disease - Product Description
Table 10: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: Digital Strip Reader - Cardiac Marker Test - Product Status
Table 12: Digital Strip Reader - Cardiac Marker Test - Product Description
Table 13: BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 14: biO1042 Test - Product Status
Table 15: biO1042 Test - Product Description
Table 16: Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Microfluidic Chip - Product Status
Table 18: Microfluidic Chip - Product Description
Table 19: Cue Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Inflammation Test Kit - Product Status
Table 21: Inflammation Test Kit - Product Description
Table 22: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: ProADM Point-of-Care - Product Status
Table 24: ProADM Point-of-Care - Product Description
Table 25: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Multianalyte 2-D Diffusion Point-Of-Care Assay - Cardiac Infarction - Product Status
Table 27: Multianalyte 2-D Diffusion Point-Of-Care Assay - Cardiac Infarction - Product Description
Table 28: Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Diagnostic Test - Cardiovascular Risk - Product Status
Table 30: Diagnostic Test - Cardiovascular Risk - Product Description
Table 31: Eachy Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Combination Kit - ACS - Product Status
Table 33: Combination Kit - ACS - Product Description
Table 34: Home Test Kit - ACS - Product Status
Table 35: Home Test Kit - ACS - Product Description
Table 36: Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Diagnostic Kit - Cardiovascular Diseases - Product Status
Table 38: Diagnostic Kit - Cardiovascular Diseases - Product Description
Table 39: MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Labchip Based Test - Cardiac Marker - Product Status
Table 41: Labchip Based Test - Cardiac Marker - Product Description
Table 42: MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Diagnostic Test - Heart Attack - Product Status(MyMD Pharmaceuticals Inc)
Table 44: Diagnostic Test - Heart Attack - Product Description(MyMD Pharmaceuticals Inc)
Table 45: Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Omega-3 Cardiac Panel - Product Status
Table 47: Omega-3 Cardiac Panel - Product Description
Table 48: Nanospot.ai Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Cardiac Marker Antibody Test - Product Status
Table 50: Cardiac Marker Antibody Test - Product Description
Table 51: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Diagnostic Test - Cardiac Panel - Product Status
Table 53: Diagnostic Test - Cardiac Panel - Product Description
Table 54: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Portable POC System - CRP - Product Status
Table 56: Portable POC System - CRP - Product Description
Table 57: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Point-Of-Care Platform - Cardiac Disorders Assay - Product Status
Table 59: Point-Of-Care Platform - Cardiac Disorders Assay - Product Description
Table 60: ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Diagnostic Test - Heart Attack - Product Status
Table 62: Diagnostic Test - Heart Attack - Product Description
Table 63: True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: TrueDX - Cardiac Health Test - Product Status
Table 65: TrueDX - Cardiac Health Test - Product Description
Table 66: Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 67: GH Assay - Heart Failure - Product Status
Table 68: GH Assay - Heart Failure - Product Description
Table 69: IGFs Assay - Heart Failure - Product Status
Table 70: IGFs Assay - Heart Failure - Product Description
Table 71: NGAL-sp Test - Heart Failure - Product Status
Table 72: NGAL-sp Test - Heart Failure - Product Description
Table 73: TSH Assay - Heart Failure - Product Status
Table 74: TSH Assay - Heart Failure - Product Description
Table 75: Glossary
2.2 List of Figures
Figure 1: Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
Figure 2: Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
Figure 3: Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
Figure 4: Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings